WEDNESDAY, Sept. 16, 2020 (HealthDay News) — When a safe and effective vaccine against COVID-19 becomes available, it is likely to take six to nine months for enough Americans to get vaccinated to have a significant impact on the pandemic, U.S. Centers for Disease Control and Prevention Director Robert Redfield, M.D., said Wednesday.
Many Doctors Misinformed About Nicotine’s Risks
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Most doctors hold misperceptions about the risks of nicotine, according to research published online Sept. 1 in the Journal of General Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Better Cardiovascular Health Linked to Lower Incident HTN
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — For adults without hypertension, better cardiovascular health as measured by Life’s Simple 7 (LS7) is associated with a lower risk for incident hypertension, according to a study published online Sept. 16 in the Journal of the American Heart Association.
Abstract/Full Text (subscription or payment may be required)
Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments
TUESDAY, Sept. 15, 2020 (HealthDay News) — In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine, a new poll shows a majority of adults do not trust what President Donald Trump has said on vaccine development.
Factor V Activity Significantly Increased in Severe COVID-19
TUESDAY, Sept. 15, 2020 (HealthDay News) — Factor V activity is significantly increased in patients with severe COVID-19, according to a study published online Aug. 24 in the American Journal of Hematology.
Abstract/Full Text (subscription or payment may be required)
Canada Reports No New COVID-19 Deaths for First Time in Six Months
MONDAY, Sept. 14, 2020 (HealthDay News) — For the first time in six months, Canada on Friday reported no new COVID-19 deaths.
Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients
MONDAY, Sept. 14, 2020 (HealthDay News) — Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients’ recovery time, according to drug company Eli Lilly.
AstraZeneca COVID-19 Vaccine Trial Restarts
MONDAY, Sept. 14, 2020 (HealthDay News) — Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.
Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
MONDAY, Sept. 14, 2020 (HealthDay News) — A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled, rather than injected, has been announced by researchers.
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Eliminating Nursing Understaffing Aids Hospital Outcomes 
Burnout and Stress Continue to Plague the Nursing Profession 
Poor Communication Major Contributor to Patient Safety Incidents 
Excessive Use of Overtime, Agency Nurse Hours Increase Rates of Patient Safety Indicators 
Standardized Discharge Framework Improves Discharge Efficiency 
Emergency Department 4+ Hour Boarding Reaches 25 Percent During Nonpeak Months 
Shift Work, Night Work Increase Risk for Common Cold in Nurses 
Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodialysis 
